Your browser doesn't support javascript.
loading
Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.
Lee, Doohyung; Na, Juri; Ryu, Jihye; Kim, Hye-Jin; Nam, Seo Hee; Kang, Minkyung; Jung, Jae Woo; Lee, Mi-Sook; Song, Haeng Eun; Choi, Jungeun; Lee, Gyu-Ho; Kim, Tai Young; Chung, June-Key; Park, Ki Hun; Kim, Sung-Hak; Kim, Hyunggee; Seo, Howon; Kim, Pilhan; Youn, Hyewon; Lee, Jung Weon.
Afiliação
  • Lee D; Department of Pharmacy, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.
  • Na J; Department of Nuclear Medicine, Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Korea.
  • Ryu J; Department of Pharmacy, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.
  • Kim HJ; Department of Pharmacy, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.
  • Nam SH; Interdisciplinary Program in Genetic Engineering, Seoul National University, Seoul, Korea.
  • Kang M; Department of Pharmacy, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.
  • Jung JW; Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Korea.
  • Lee MS; Interdisciplinary Program in Genetic Engineering, Seoul National University, Seoul, Korea.
  • Song HE; Department of Pharmacy, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.
  • Choi J; Department of Pharmacy, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.
  • Lee GH; Interdisciplinary Program in Genetic Engineering, Seoul National University, Seoul, Korea.
  • Kim TY; Department of Pharmacy, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.
  • Chung JK; Department of Pharmacy, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.
  • Park KH; Department of Nuclear Medicine, Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Korea.
  • Kim SH; Cancer Imaging Center, Seoul National University Hospital, Seoul, Korea.
  • Kim H; Division of Applied Life Science, Gyeongsang National University, Jinju, Korea.
  • Seo H; School of Life Sciences and Biotechnology, Korea University, Seoul, Korea.
  • Kim P; School of Life Sciences and Biotechnology, Korea University, Seoul, Korea.
  • Youn H; Graduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology, Daejeon, Korea.
  • Lee JW; Graduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology, Daejeon, Korea.
Hepatology ; 61(6): 1978-97, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25627085
ABSTRACT
UNLABELLED Tumor metastasis involves circulating and tumor-initiating capacities of metastatic cancer cells. Epithelial-mesenchymal transition (EMT) is related to self-renewal capacity and circulating tumor cell (CTC) characteristics for tumor metastasis. Although tumor metastasis is a life-threatening, complicated process that occurs through circulation of tumor cells, mechanistic aspects of self-renewal and circulating capacities have been largely unknown. Hepatic transmembrane 4 L six family member 5 (TM4SF5) promotes EMT for malignant growth and migration, so it was rationalized that TM4SF5, as a hepatocellular carcinoma (HCC) biomarker, might be important for metastatic potential. Here, self-renewal capacity by TM4SF5 was mechanistically explored using hepatocarcinoma cells with or without TM4SF5 expression, and we explored whether they became CTCs using mouse liver-orthotopic model systems. We found that TM4SF5-dependent sphere growth correlated with CD24(-) , aldehyde dehydrogenase (ALDH) activity, as well as a physical association between CD44 and TM4SF5. Interaction between TM4SF5 and CD44 was through their extracellular domains with N-glycosylation modifications. TM4SF5/CD44 interaction activated proto-oncogene tyrosine-protein kinase Src (c-Src)/signal transducer and activator of transcription 3 (STAT3)/Twist-related protein 1 (Twist1)/B-cell-specific Moloney murine leukemia virus integration site 1 (Bmi1) signaling for spheroid formation, whereas disturbing the interaction, expression, or activity of any component in this signaling pathway inhibited spheroid formation. In serial xenografts using 200∼5,000 cells per injection, TM4SF5-positive tumors exhibited subpopulations with locally increased CD44 expressions, supporting for tumor cell differentiation. TM4SF5-positive, but not TM4SF5- or CD44-knocked-down, cells were identified circulating in blood 4-6 weeks after orthotopic liver injection using in vivo laser scanning endomicroscopy. Anti-TM4SF5 reagent blocked their metastasis to distal intestinal organs.

CONCLUSION:

TM4SF5 promotes self-renewal and CTC properties supported by TM4SF5(+) /CD44(+(TM4SF5-bound)) /ALDH(+) /CD24(-) markers during HCC metastasis.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Receptores de Hialuronatos / Neoplasias Hepáticas Experimentais / Proteínas de Membrana / Células Neoplásicas Circulantes Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Receptores de Hialuronatos / Neoplasias Hepáticas Experimentais / Proteínas de Membrana / Células Neoplásicas Circulantes Idioma: En Ano de publicação: 2015 Tipo de documento: Article